Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death
Open Access
- 22 April 2020
- Vol. 9 (4), 1033
- https://doi.org/10.3390/cells9041033
Abstract
Doxorubicin is a strong inducer of immunogenic cell death (ICD), but it is ineffective in P-glycoprotein (Pgp)-expressing cells. Indeed, Pgp effluxes doxorubicin and impairs the immunesensitizing functions of calreticulin (CRT), an “eat-me” signal mediating ICD. It is unknown if classical Pgp inhibitors, designed to reverse chemoresistance, may restore ICD. We addressed this question by using Pgp-expressing cancer cells, treated with Tariquidar, a clinically approved Pgp inhibitor, and R-3 compound, a N,N-bis(alkanol)amine aryl ester derivative with the same potency of Tariquidar as Pgp inhibitor. In Pgp-expressing/doxorubicin-resistant cells, Tariquidar and R-3 increased doxorubicin accumulation and toxicity, reduced Pgp activity, and increased CRT translocation and ATP and HMGB1 release. Unexpectedly, only R-3 promoted phagocytosis by dendritic cells and activation of antitumor CD8+T-lymphocytes. Although Tariquidar did not alter the amount of Pgp present on cell surface, R-3 promoted Pgp internalization and ubiquitination, disrupting its interaction with CRT. Pgp knock-out restores doxorubicin-induced ICD in MDA-MB-231/DX cells that recapitulated the phenotype of R-3-treated cells. Our work demonstrates that plasma membrane-associated Pgp prevents a complete ICD notwithstanding the release of ATP and HMGB1, and the exposure of CRT. Pharmacological compounds reducing Pgp activity and amount may act as promising chemo- and immunesensitizing agents.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG21408)
This publication has 47 references indexed in Scilit:
- Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes compositionMolecular Cancer, 2013
- ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapyOncoImmunology, 2013
- Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer CellsPLOS ONE, 2013
- Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39OncoImmunology, 2012
- CD73-Deficient Mice Are Resistant to CarcinogenesisCancer Research, 2012
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cellsJournal of Cellular and Molecular Medicine, 2011
- iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cellsMolecular Cancer, 2009
- Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance ModulatorsThe AAPS Journal, 2009
- Pumping of Drugs by P-Glycoprotein: A Two-Step Process?The Journal of pharmacology and experimental therapeutics, 2003